Navigation Links
Medco Acquires Leading Genetics Healthcare Company, DNA Direct
Date:2/2/2010

FRANKLIN LAKES, N.J. and SAN FRANCISCO, Feb. 2 /PRNewswire-FirstCall/ -- Committed to being at the forefront of translating personalized medicine from the science to its daily practice in healthcare, Medco Health Solutions, Inc. (NYSE: MHS) today announced the acquisition of DNA Direct, Inc., a leader in providing guidance and decision support for genomic medicine to patients, providers, payors and employees. Financial details of the acquisition were not released.

"DNA Direct has been a recognized pioneer in assimilating knowledge about molecular diagnostic testing and deploying certified genetics professionals to help rationalize the opportunities and implications faced by many in this new and rapidly evolving field," said David B. Snow Jr., Medco chairman and chief executive officer.

By integrating DNA Direct's physician, client and patient support services and capabilities with Medco's growing portfolio of personalized medicine capabilities and extensive customer base, Medco intends to deliver a broader suite of precision health services, ranging from consumer education to clinical decision support.

"Medco is simply the most innovative and forward thinking healthcare company in the industry today," said Ryan Phelan, DNA Direct founder and CEO. "Having spent the past 25 years as an entrepreneur translating healthcare information to patients, I can't think of a better partner to take personalized medicine to the next level."

DNA Direct is the first genomics-focused company offering URAC-accredited utilization management programs to help payors ensure the appropriate use of the more than 2,000 genetic and molecular tests available today. URAC is a Washington D.C.-based health care accrediting organization that establishes quality standards for the health care industry. DNA Direct's national call center of genetic experts, complemented by online decision support services help physicians and patients determine if genetic tests are appropriate and how to use genetic test results to guide clinical decisions. Medco's existing personalized medicine approach encompasses a robust pipeline of important pharmacogenetic research, turnkey testing programs for drugs like tamoxifen and warfarin, and warnings on over 50 drug-gene interactions, which are used by Medco's specialist pharmacists to inform physicians and patients about potential therapy adjustments to ensure the safety and efficacy of the treatment.

"When a Fortune 50 company like Medco makes a commitment to personalized medicine with an acquisition like this, it's proof positive that we are at a turning point in the healthcare industry," said Sharon Terry, president and chief executive officer of Genetic Alliance. "Integrating Medco's phenomenal capacity to respond to its members, with the innovative and creative patient-focused services of DNA Direct is a win for all consumers."

The DNA Direct purchase builds upon Medco's commitment to advancing pharmacogenomics (PGx), a cornerstone of which is the company's Personalized Medicine Research Center.  The research center is dedicated to furthering the understanding of the impact of genetics on patient medication response and applying that science to clinical practice. As knowledge is gained through the research, applications will be rolled out to the broader client base within Medco's precision health services.

"By integrating proven state-of-the-art science into every day care, we are providing patients and providers with actionable information that drives more personalized care to achieve higher efficacy or improved safety," said Dr. Robert Epstein, Medco's chief medical officer. "We have already started this today with our existing Personalized Medicine programs. DNA Direct will serve to accelerate our speed-to-market implementation capabilities, transforming research into actionable services to meet the demands of our clients and patients."

About Medco

Medco Health Solutions, Inc. (NYSE: MHS) is pioneering the world's most advanced pharmacy® and its clinical research and innovations are part of Medco making medicine smarter™ for more than 60 million members.

With more than 20,000 employees dedicated to improving patient health and reducing costs for a wide range of public and private sector clients, and 2008 revenue exceeding $51 billion, Medco ranks 45th on the Fortune 500 list and is named among the world's most innovative, most admired and most trustworthy companies. 

For more information, go to http://www.medcohealth.com.

About DNA Direct

DNA Direct was founded in 2005 to deliver guidance and decision support for genomic medicine to patients, providers and payers -- reducing health risks, preventing disease, and better targeting therapies.  The first genomics-focused company to receive full URAC accreditation for utilization management in the U.S., DNA Direct's comprehensive clinical programs combine proprietary technology with genetic expertise including a national call center of genetic experts, web-based applications, and educational resources and training. The company is based in San Francisco and was backed by Firefly Investments and Lemhi Ventures. For more information, visit www.dnadirect.com.

This press release contains "forward-looking statements" as that term is defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks and uncertainties that may cause results to differ materially from those set forth in the statements. No forward-looking statement can be guaranteed, and actual results may differ materially from those projected. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise. Forward-looking statements in this press release should be evaluated together with the risks and uncertainties that affect our business, particularly those mentioned in the Risk Factors section of the Company's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q filed with the Securities and Exchange Commission.  

SOURCE Medco Health Solutions, Inc.

RELATED LINKS
http://www.medcohealth.com

'/>"/>

SOURCE Medco Health Solutions, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. MedCom USAs Subsidiary Card Activation Technologies, Inc.s SB2 Registration Declared Effective by SEC
2. Medco Unveils Three New Medicare Prescription Drug Plan Options for 2008 to Provide Seniors More Choice, Better Value and Specialist Pharmacists
3. Medco Announces Date for Third-Quarter 2007 Financial Results
4. Six Olympic Legends Battling Chronic Diseases Lead Revolution in Advancing Pharmacy Care as Medco Launches the Tour of Champions
5. Medco, LabCorp Strike Strategic Agreement for Research on Personalized Medicine and Pharmacogenomics
6. Medco to Build Worlds Largest, Most Advanced Automated Pharmacy in Central Indiana
7. Medco Elects Myrtle Potter, William Roper to Board of Directors
8. Medco CEO to Present at the Merrill Lynch & Co., Inc. 2007 Health Services Investor Conference
9. Medco Announces Two-For-One Stock Split
10. URAC Names Medco as a Finalist in First-ever Best Practices in Consumer Empowerment and Protection Awards
11. MedcomSoft appoints former U.S. presidential health advisor, James Haveman, to health Care advisory board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... ... 12, 2016 , ... Erlanger Agency has announced a new partnership in its ... campaign focuses on the fight against breast cancer, fundraising for a local woman named ... . , Carmen is a loving single mother of two boys who also serves ...
(Date:2/12/2016)... , ... February 12, 2016 , ... Donor Network West, ... California and Nevada, announced a partnership with San Ramon Regional Medical Center. Under the ... hospital’s facilities as a way to accommodate a more certain time frame for donor ...
(Date:2/12/2016)... ... ... For Coast Dental dentist Everet Lake, DDS, the smiles began at dawn. ... before 7 a.m. to volunteer at Friday’s Dentistry from the Heart event in New ... help hundreds of uninsured and underinsured people receive much-needed dental care. , This ...
(Date:2/12/2016)... ... February 12, 2016 , ... Mediaplanet today announces the ... print component of “Revolutionizing Cancer Care” is distributed within the February 12 issue ... with a circulation of approximately 250,000 copies and an estimated readership of 750,000 ...
(Date:2/12/2016)... , ... February 12, 2016 , ... ... Drug Categories: Strategies for Health Plans and PBMs,” an upcoming Feb. 24 webinar ... affordability and access in big-dollar therapeutic categories, such as the $1,000-per-pill hepatitis C ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... 2016 (Kanadische ... http://www.sedar.com ) und der Website ... --> http://www.sedar.com ) und ... abrufbar.    --> Telesta ... Konzernabschluss des zweiten Quartals und die ...
(Date:2/12/2016)... 2016  Sequent Medical, Inc. gab heute bekannt, ... eine Studie zur Sicherheit und Wirksamkeit des WEB™-Systems ... Behandlung von rupturierten intrakraniellen Aneurysmen begonnen hat. Prof. ... an der Universitätsklinik Bicètre in Paris ... den ersten Patienten aufgenommen. Im Rahmen ...
(Date:2/12/2016)... AUSTIN, Texas , Feb. 12, 2016 ... Institute for Robotic Surgery at St. David,s North Austin ... the da Vinci ® Xi ® Surgical ... ® 7000dV. Thiru Lakshman , M.D., ... performed a total proctocolectomy utilizing Integrated Table Motion technology, ...
Breaking Medicine Technology: